Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis.
about
The CD20 homologue MS4A4 directs trafficking of KIT toward clathrin-independent endocytosis pathways and thus regulates receptor signaling and recyclingRituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.MS4A Cluster in Alzheimer's Disease.
P2860
Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-MS4a4B treatment abrogate ...... autoimmune encephalomyelitis.
@en
Anti-MS4a4B treatment abrogate ...... autoimmune encephalomyelitis.
@nl
type
label
Anti-MS4a4B treatment abrogate ...... autoimmune encephalomyelitis.
@en
Anti-MS4a4B treatment abrogate ...... autoimmune encephalomyelitis.
@nl
prefLabel
Anti-MS4a4B treatment abrogate ...... autoimmune encephalomyelitis.
@en
Anti-MS4a4B treatment abrogate ...... autoimmune encephalomyelitis.
@nl
P2093
P2860
P1433
P1476
Anti-MS4a4B treatment abrogate ...... autoimmune encephalomyelitis.
@en
P2093
Abdolmohamad Rostami
Gregory B Carey
Guang-Xian Zhang
Jianke Zhang
Mark S Williams
Yaping Yan
P2860
P2888
P304
P356
10.1007/S10495-013-0870-2
P577
2013-09-01T00:00:00Z